China Drug Regulator Mulls Tightening Conditional Approvals

 
• By Dexter Jie Yan

A senior official at China’s National Medical Products Administration recently disclosed that the agency was moving to "rigorously" prevent the accelerated approval pathway from becoming distorted.

NMPA on conditional approval
China's top drug regulator taking steps to prevent distortion of accelerated approval pathway • Source: Shutterstock

More from China

More from Asia